PEOPLE

Search for name:

Division Chief

No results.

Faculty

Israel Rubinstein, MD

Professor of Medicine
Home Phone: 312-996-8039 Home Phone: 312-996-2740 Website: Clinical Profile Website: Research Lab Website: PubMed
Photo of Israel Rubinstein MD

Biographical Info

Education History

Medical School: Hebrew University, Jerusalem, Israel
Residency: The Chaim Sheba Medical Center, Tel-Hashomer, Israel
Fellowship: University of Toronto, Toronto, Ontario, Canada

List Accomplishments/Awards/Honor 

https://www.ensol-therapies.com/

Dr Rubinstein holds several issued and pending US and international patents and has authored more than 200 peer-reviewed scientific papers. He is Editor-in-Chief, Nanotechnology, Science and Applications, Clinical Editor, Nanomedicine: Nanotechnology, Biology and Medicine and Associate Editor, International Journal of Nanomedicine. Dr. Rubinstein co-founded ResQ Pharma, Inc. that has recently submitted an IND application to the US FDA, and EnSol Therapeutics, LLC. Dr. Rubinstein is Board Member and Director of Advanced Life Sciences, a publicly-traded biopharmaceutical company in Woodridge, Illinois, USA.

Categories: DOM – Pulmonary – Faculty
Updated 1 day ago.

Research Faculty

Israel Rubinstein, MD

Professor of Medicine
Home Phone: 312-996-8039 Home Phone: 312-996-2740 Website: Clinical Profile Website: Research Lab Website: PubMed
Photo of Israel Rubinstein MD

Biographical Info

Education History

Medical School: Hebrew University, Jerusalem, Israel
Residency: The Chaim Sheba Medical Center, Tel-Hashomer, Israel
Fellowship: University of Toronto, Toronto, Ontario, Canada

List Accomplishments/Awards/Honor 

https://www.ensol-therapies.com/

Dr Rubinstein holds several issued and pending US and international patents and has authored more than 200 peer-reviewed scientific papers. He is Editor-in-Chief, Nanotechnology, Science and Applications, Clinical Editor, Nanomedicine: Nanotechnology, Biology and Medicine and Associate Editor, International Journal of Nanomedicine. Dr. Rubinstein co-founded ResQ Pharma, Inc. that has recently submitted an IND application to the US FDA, and EnSol Therapeutics, LLC. Dr. Rubinstein is Board Member and Director of Advanced Life Sciences, a publicly-traded biopharmaceutical company in Woodridge, Illinois, USA.

Categories: DOM – Pulmonary – Faculty
Updated 1 day ago.

APRN Faculty

Israel Rubinstein, MD

Professor of Medicine
Home Phone: 312-996-8039 Home Phone: 312-996-2740 Website: Clinical Profile Website: Research Lab Website: PubMed
Photo of Israel Rubinstein MD

Biographical Info

Education History

Medical School: Hebrew University, Jerusalem, Israel
Residency: The Chaim Sheba Medical Center, Tel-Hashomer, Israel
Fellowship: University of Toronto, Toronto, Ontario, Canada

List Accomplishments/Awards/Honor 

https://www.ensol-therapies.com/

Dr Rubinstein holds several issued and pending US and international patents and has authored more than 200 peer-reviewed scientific papers. He is Editor-in-Chief, Nanotechnology, Science and Applications, Clinical Editor, Nanomedicine: Nanotechnology, Biology and Medicine and Associate Editor, International Journal of Nanomedicine. Dr. Rubinstein co-founded ResQ Pharma, Inc. that has recently submitted an IND application to the US FDA, and EnSol Therapeutics, LLC. Dr. Rubinstein is Board Member and Director of Advanced Life Sciences, a publicly-traded biopharmaceutical company in Woodridge, Illinois, USA.

Categories: DOM – Pulmonary – Faculty
Updated 1 day ago.

Staff

Israel Rubinstein, MD

Professor of Medicine
Home Phone: 312-996-8039 Home Phone: 312-996-2740 Website: Clinical Profile Website: Research Lab Website: PubMed
Photo of Israel Rubinstein MD

Biographical Info

Education History

Medical School: Hebrew University, Jerusalem, Israel
Residency: The Chaim Sheba Medical Center, Tel-Hashomer, Israel
Fellowship: University of Toronto, Toronto, Ontario, Canada

List Accomplishments/Awards/Honor 

https://www.ensol-therapies.com/

Dr Rubinstein holds several issued and pending US and international patents and has authored more than 200 peer-reviewed scientific papers. He is Editor-in-Chief, Nanotechnology, Science and Applications, Clinical Editor, Nanomedicine: Nanotechnology, Biology and Medicine and Associate Editor, International Journal of Nanomedicine. Dr. Rubinstein co-founded ResQ Pharma, Inc. that has recently submitted an IND application to the US FDA, and EnSol Therapeutics, LLC. Dr. Rubinstein is Board Member and Director of Advanced Life Sciences, a publicly-traded biopharmaceutical company in Woodridge, Illinois, USA.

Categories: DOM – Pulmonary – Faculty
Updated 1 day ago.

INSTRUCTIONS: In order to add a sidebar anchor:

  1. Duplicate the existing item, listed as a 1/6 text field. (Or create a 1/6 column and add a text field, modify the class so it’s exactly “additionalAnchor”).
  2. Modify the text field inside the 1/6 column. Inside there, modify the HYPERLINK so that it would go to a corresponding section with a “#” in front of it. (Example, we have a “chief” section on the page, then it would make sense to have the hyperlink go to “#chief”)
  3. Then change the hyperlink TEXT to a appropriate label.
  4. IMPORTANT: If not done already, go into that CONTAINER that corresponds to your anchor (i.e. Meet The Chiefs), and add an ID matching the anchor’s HYPERLINK WITHOUT the “#”, i.e. “chief”.
  5. (If using side bar widget box, then there’s a saved copy of a widget box COLUMN, grab it in the column library, it should 1/6 of a length of a column.)

NOTE: Order added to the sidebar is from last to first.